Summary of Incidents
1. Information for this disease was retrieved from the Technical Working Group and Situation Reports
2. Case Fatality Rate (CFR) for this disease is reported for confirmed cases only.
3. CFR for this disease is reported for total cases i.e. suspected + confirmed.
4. Information for sentinel influenza was retrieved from the laboratory.
Cerebrospinal Meningitis (CSM)
Key points
o There were 70 suspected cases of Cerebrospinal meningitis (CSM) reported from 24 LGAs in seven states. There was one laboratory confirmed case and four deaths were reported.
Actions
To date:
o National CSM TWG meets weekly to review reports from states and plan appropriately.
Yellow Fever (YF)
Key points
o There were 73 suspected cases of Yellow Fever (YF) reported from 55 LGAs in 25 states. There was no laboratory-confirmed case and no death was recorded.
Actions
To date:
o National YF multi-partner Technical Working Group (TWG) continues to coordinate activities across states.
o Daily monitoring and analysis of surveillance data across the country to guide response activities.
o Coordination of yellow fever sample management and transportation from all states to the regional reference laboratories
o Regular testing of yellow fever samples in all the testing laboratories
Cholera
Key points
o There were 74 suspected cases of Cholera reported from 20 LGAs in nine states. There was no laboratory confirmed case and two deaths were recorded.
Actions
To date
o National Cholera Multi-Sectoral Technical Working Group (TWG) is monitoring all states and supporting affected states.
Measles
Key points
o There were 630 suspected cases of Measles reported from 236 LGAs in 35 states and FCT. There were 114 laboratory confirmed cases and one death was recorded.
Actions
To date
o National Measles TWG is closely monitoring measles surveillance data and providing feedback to relevant agencies and development partners.
Mpox
Key points
o There were 25 suspected cases of Mpox reported from 14 LGAs in nine states. There were two laboratory confirmed cases and no death was recorded.
Actions
To date
o National Mpox Technical Working Group (TWG) is monitoring activities in all states.
Acute Flaccid Paralysis (AFP)
Key points
o There were 184 suspected cases of AFP reported from 140 LGAs in 32 states and FCT. There was no laboratory confirmed case and no death was recorded.
National Influenza Sentinel Surveillance
Coronavirus Disease (COVID-19)
Key points
o There were 188 suspected cases of COVID-19 reported from 38 LGAs in seven states and FCT. There were 188 confirmed cases and no death recorded
Actions
To date:
o Multi-sectoral Public Health Emergency Operation Centres (PHEOC) activated at the National and affected States
Diphtheria
Key points
o There were 517 suspected cases of Diphtheria reported from 53 LGAs in nine states. There were 222 confirmed cases, and two deaths were recorded.
Actions
To date
o The National Diphtheria Technical Working Group (TWG) is monitoring activities in all states.
o Harmonisation of surveillance and laboratory data from across states and laboratories.
o Provision of off-site surveillance support to affected States.
Event-Based Surveillance (EBS)
Key points
For the reporting week 6:
o 77 Calls were successfully routed to agents and answered
o 14 calls not routed to agents (Failed call)
o 91 total number of calls (successful and failed)
o 0 number of SMS received
o 0 WhatsApp/live chat messages received
o Percentage of failed to total inbound calls 15.4%
o 0 signal picked
For week 1 – 6:
o 484 calls were successfully routed to agents and answered
o 29 calls not routed to agents (Failed call)
o 513 total inbound calls recorded
o Percentage of failed to total inbound calls: 5.7%
o 2 Signals picked and escalated
Categories of Calls
o General inquiries 31
o Hoax call and others 34
o Report of health conditions 6
o Inquiry on Lassa fever 18
o Inquiry on malaria vaccine 0
o Health Declaration form-related queries 0
o Inquiries on Diphtheria symptoms, treatment, and Vaccine 0
o Inquiries on yellow fever vaccine 0
o Inquiries on Lassa fever vaccine 2
o COVID-19 vaccination inquiries 0